Mersana Therapeutics, Inc. Finance Lease, Liability
Mersana Therapeutics, Inc. had Finance Lease, Liability of $197.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:FinanceLeaseLiability · last filed 2024-02-28
- 2023-12-31: Finance Lease, Liability $197.00K.
- 2022-12-31: Finance Lease, Liability $444.00K.
- 2021-12-31: Finance Lease, Liability $688.00K.
- 2021-09-30: Finance Lease, Liability $755.00K.
| Period end | Finance Lease, Liability |
|---|---|
| 2023-12-31 | $197.00K 10-K · filed 2024-02-28 |
| 2022-12-31 | $444.00K 10-K · filed 2023-02-28 |
| 2021-12-31 | $688.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $755.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $417.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $452.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $267.00K 10-K · filed 2021-02-26 |
| 2020-09-30 | $291.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $314.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $338.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $362.00K 10-K · filed 2020-02-28 |
| 2019-09-30 | $429.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $429.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $429.00K 10-Q · filed 2019-05-09 |